Second degree AV block primary prevention: Difference between revisions
Jump to navigation
Jump to search
| Line 22: | Line 22: | ||
* [[Pacemakers]] can usually provide adequate treatment of the symptoms of [[AV bloc]]k, no preventive or curative strategies are currently used in [[clinical]] practice. | * [[Pacemakers]] can usually provide adequate treatment of the symptoms of [[AV bloc]]k, no preventive or curative strategies are currently used in [[clinical]] practice. | ||
* | * | ||
*No previous study, to our knowledge, has reported the population-based characteristics associated with incident AV block. | *No previous study, to our knowledge, has reported the population-based characteristics associated with incident AV block. | ||
* Atrioventricular block is associated with multiple known [[cardiovascular]] [[risk factors]] and [[conditions]]. | * Atrioventricular block is associated with multiple known [[cardiovascular]] [[risk factors]] and [[conditions]]. | ||
Revision as of 05:34, 11 July 2021
|
Second degree AV block Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Second degree AV block primary prevention On the Web |
|
American Roentgen Ray Society Images of Second degree AV block primary prevention |
|
Risk calculators and risk factors for Second degree AV block primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Effective measures for primary prevention of atrioventricular block include treatment of hypertension and maintenance of normal blood glucose levels. Atrioventricular (AV) block is a common reason for pacemaker implantation, and the number of pacemaker implantations is increasing. Atrioventricular block most commonly occurs in the absence of significant cardiac disease and is generally attributed to idiopathic fibrosis of the conduction system. By definition, the cause of that fibrosis remains unknown without primary prevention strategy.
Primary prevention
- Effective measures for primary prevention of atrioventricular block include treatment of hypertension and maintenance of normal blood glucose levels.
- Atrioventricular (AV) block is a common reason for pacemaker implantation, and the number of pacemaker implantations is increasing.
- Atrioventricular block most commonly occurs in the absence of significant cardiac disease and is generally attributed to idiopathic fibrosis of the conduction system.
- By definition, the cause of that fibrosis remains unknown without primary prevention strategy.
- Pacemaker implantations as a treatment for atrioventricular (AV) block are increasing worldwide. Prevention strategies for AV block are lacking because modifiable risk factors have not yet been identified[1][2][3].
- Pacemakers can usually provide adequate treatment of the symptoms of AV block, no preventive or curative strategies are currently used in clinical practice.
- No previous study, to our knowledge, has reported the population-based characteristics associated with incident AV block.
- Atrioventricular block is associated with multiple known cardiovascular risk factors and conditions.
- Modifiable risk factors of elevated systolic blood pressure and a higher fasting glucose level were independently associated with AV block.
- Taken together, these 2 directly modifiable variables potentially explain more than half of allAV blocks in a community-based population.[4].
- Effective treatment of hypertension and maintenance of normal blood glucose levels may be useful strategies in preventing AV block.
References
- ↑ Kerola T, Eranti A, Aro AL, Haukilahti MA, Holkeri A, Junttila MJ, Kenttä TV, Rissanen H, Vittinghoff E, Knekt P, Heliövaara M, Huikuri HV, Marcus GM (May 2019). "Risk Factors Associated With Atrioventricular Block". JAMA Netw Open. 2 (5): e194176. doi:10.1001/jamanetworkopen.2019.4176. PMC 6632153 Check
|pmc=value (help). PMID 31125096. - ↑ Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L (2004). "Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study". Lancet. 364 (9438): 937–52. doi:10.1016/S0140-6736(04)17018-9. PMID 15364185.
- ↑ LEV M (November 1964). "ANATOMIC BASIS FOR ATRIOVENTRICULAR BLOCK". Am. J. Med. 37: 742–8. doi:10.1016/0002-9343(64)90022-1. PMID 14237429.
- ↑ Epstein AE, Dimarco JP, Ellenbogen KA, Estes NA, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO (June 2008). "ACC/AHA/HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary". Heart Rhythm. 5 (6): 934–55. doi:10.1016/j.hrthm.2008.04.015. PMID 18534377.